Katner S, Bredhold K, Steagall K, Bell R, Neal Beliveau B, Cheong M, et al. Caenorhabditis elegans as a model system to identify therapeutics for alcohol use disorders. Behav Brain Res. 2019;365:7-16 pubmed publisher

Floettmann E, Bui K, Sostek M, Payza K, Eldon M. Pharmacologic Profile of Naloxegol, a Peripherally Acting µ-Opioid Receptor Antagonist, for the Treatment of Opioid-Induced Constipation. J Pharmacol Exp Ther. 2017;361:280-291 pubmed publisher

Cai Y, Yang L, Hu G, Chen X, Niu F, Yuan L, et al. Regulation of morphine-induced synaptic alterations: Role of oxidative stress, ER stress, and autophagy. J Cell Biol. 2016;215:245-258 pubmed

Kaufling J, Aston Jones G. Persistent Adaptations in Afferents to Ventral Tegmental Dopamine Neurons after Opiate Withdrawal. J Neurosci. 2015;35:10290-303 pubmed publisher

Moreno Vicente R, Fernández Nieva Z, Navarro A, Gascón Crespí I, Farré Albaladejo M, Igartua M, et al. Development and validation of a bioanalytical method for the simultaneous determination of heroin, its main metabolites, naloxone and naltrexone by LC-MS/MS in human plasma samples: Application to a clinical trial of oral administration of a heroin/n. J Pharm Biomed Anal. 2015;114:105-12 pubmed publisher

Verplaetse T, Czachowski C. Low-dose prazosin alone and in combination with propranolol or naltrexone: effects on ethanol and sucrose seeking and self-administration in the P rat. Psychopharmacology (Berl). 2015;232:2647-57 pubmed publisher

Miranda H, Sierralta F, Lux S, Troncoso R, Ciudad N, Zepeda R, et al. Involvement of nitridergic and opioidergic pathways in the antinociception of gabapentin in the orofacial formalin test in mice. Pharmacol Rep. 2015;67:399-403 pubmed publisher

Xu J, Zhao Q, Wei L, Yang Y, Xu R, Yu N, et al. Phytochemical composition and antinociceptive activity of Bauhinia glauca subsp. hupehana in rats. PLoS ONE. 2015;10:e0117801 pubmed publisher

Chumakov I, Milet A, Cholet N, Primas G, Boucard A, Pereira Y, et al. Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy. Orphanet J Rare Dis. 2014;9:201 pubmed publisher

Abdelkader H, Pierscionek B, Alany R. Novel in situ gelling ocular films for the opioid growth factor-receptor antagonist-naltrexone hydrochloride: fabrication, mechanical properties, mucoadhesion, tolerability and stability studies. Int J Pharm. 2014;477:631-42 pubmed publisher

Sanchez Roige S, Ripley T, Stephens D. Alleviating waiting impulsivity and perseverative responding by μ-opioid receptor antagonism in two inbred mouse strains. Psychopharmacology (Berl). 2015;232:1483-92 pubmed publisher

Qiu Y, He X, Zhang Y, Li J. Discriminative stimulus effects of the novel imidazoline Iâ‚‚ receptor ligand CR4056 in rats. Sci Rep. 2014;4:6605 pubmed publisher

Avena N, Bocarsly M, Murray S, Gold M. Effects of baclofen and naltrexone, alone and in combination, on the consumption of palatable food in male rats. Exp Clin Psychopharmacol. 2014;22:460-7 pubmed publisher

Gassaway M, Rives M, Kruegel A, Javitch J, Sames D. The atypical antidepressant and neurorestorative agent tianeptine is a μ-opioid receptor agonist. Transl Psychiatry. 2014;4:e411 pubmed publisher

Ciccocioppo R, Stopponi S, Economidou D, Kuriyama M, Kinoshita H, Heilig M, et al. Chronic treatment with novel brain-penetrating selective NOP receptor agonist MT-7716 reduces alcohol drinking and seeking in the rat. Neuropsychopharmacology. 2014;39:2601-10 pubmed publisher

Norwood A, Al Chaer E, Fantegrossi W. Predisposing effects of neonatal visceral pain on abuse-related effects of morphine in adult male Sprague Dawley rats. Psychopharmacology (Berl). 2014;231:4281-9 pubmed publisher

Wright F, Rodgers R. Behavioural profile of exendin-4/naltrexone dose combinations in male rats during tests of palatable food consumption. Psychopharmacology (Berl). 2014;231:3729-44 pubmed publisher

Hofmann T, Schafer S, Linseisen M, Sytik L, Gudermann T, Chubanov V. Activation of TRPM7 channels by small molecules under physiological conditions. Pflugers Arch. 2014;466:2177-89 pubmed publisher

Cordery S, Taverner A, Ridzwan I, Guy R, Delgado Charro M, Husbands S, et al. A non-rewarding, non-aversive buprenorphine/naltrexone combination attenuates drug-primed reinstatement to cocaine and morphine in rats in a conditioned place preference paradigm. Addict Biol. 2014;19:575-86 pubmed publisher

Zagon I, Klocek M, Sassani J, McLaughlin P. Dry eye reversal and corneal sensation restoration with topical naltrexone in diabetes mellitus. Arch Ophthalmol. 2009;127:1468-73 pubmed publisher

Yuan J, Johnson R, Huang R, Wichterman J, Jiang H, Hayton K, et al. Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum. Nat Chem Biol. 2009;5:765-71 pubmed publisher

Diamandis P, Wildenhain J, Clarke I, Sacher A, Graham J, Bellows D, et al. Chemical genetics reveals a complex functional ground state of neural stem cells. Nat Chem Biol. 2007;3:268-73 pubmed

Powell K, Holtzman S. Differential antagonism of the rate-decreasing effects of kappa-opioid receptor agonists by naltrexone and norbinaltorphimine. Eur J Pharmacol. 1999;377:21-8 pubmed

Bienkowski P, Kostowski W, Koros E. Ethanol-reinforced behaviour in the rat: effects of naltrexone. Eur J Pharmacol. 1999;374:321-7 pubmed